U.S. President Donald Trump plans to link the use of acetaminophen in pregnancy with the risk of autism in an announcement he will make this Monday, September 22, at the White House, despite the fact that there is no scientific evidence to support this claim, according to media reports.
Donald Trump, accompanied by health authorities, is expected to warn pregnant women about the use of acetaminophen, the active ingredient in Tylenol and one of the most widely used drugs worldwide, The Washington Post reported citing multiple sources close to the GOP.
Trump links paracetamol to autism
In addition, they are expected to discuss a treatment for autism based on leucovorin, considered a folic acid analogue.
“I think it will be a very important press conference and we want things to go into effect immediately.”
Donald Trump told reporters aboard Air Force One on Sunday.
The president suggested that Tylenol (a popular brand of paracetamol or acetaminophen) “was a very important factor” in the risk of autism.
And that much research has been done on the subject, a claim that has been disproved by scientists who have assured that there is no link between paracetamol and the disease.
Statements generate unnecessary alarm
Public health experts have expressed concern about such statements.
As they could generate unnecessary alarm in pregnant women who rely on paracetamol as a safe analgesic to control minor aches and fevers.
Medical organizations recalled that the FDA (Food and Drug Administration) has not found conclusive evidence linking acetaminophen to autism.
It also warns that restricting their use could lead patients to resort to less safe drugs.
For more information, visit QuéOnnda.com.
